Skip to main content

Table 3 Characteristics of the matched study population in the SA-2

From: Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients

  

Surgery [MIE]

 

CCRT

 

Standardized differencea

  

Number or mean (sd)a

(%)a

Number or mean (sd)a

(%)a

Age

 

56.38 (8.21)

 

55.35 (10.58)

 

0.11

Gender

Female

4

(5)

4

(5)

0.00

Male

78

(95)

78

(95)

 

Residency

Non-north

57

(70)

52

(63)

0.13

North

25

(30)

30

(37)

 

Tumor size

≤ 5 cm

31

(38)

31

(38)

0.00

> 5 cm

51

(62)

51

(62)

 

Differentiation

Poorly/undifferentiated

31

(38)

30

(37)

0.03

Well/moderately

51

(62)

52

(63)

 

RT delivery

Non-IGRT

70

(85)

68

(83)

0.07

IGRT

12

(15)

14

(17)

 

Institution

Low volume

23

(28)

25

(30)

0.05

High volume

59

(72)

57

(70)

 

Use of PET

Without

7

(9)

11

(13)

0.16

With

75

(91)

71

(87)

 
  1. The nonoverlapped covariable (location) was not included in this matching
  2. sd standard deviation, RT radiotherapy, IGRT image-guided RT, PET positron emission tomography, MIE minimally invasive esophagectomy, CCRT concurrent chemoradiotherapy
  3. aRounded